Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Michelet

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Antimicrobial Chemotherapy|May 17, 2021
Quantification of persister formation of Escherichia coli leveraging electronic cell counting and semi-mechanistic pharmacokinetic/pharmacodynamic modellingJohanna Seeger, Robin Michelet, Charlotte Kloft
Current Pharmaceutical Design|October 10, 2017
PBPK in Preterm and Term Neonates: A ReviewRobin Michelet, Jan Van Bocxlaer, An Vermeulen
Journal of Clinical Pharmacology|October 15, 2024
Exploring the Impact of Developmental Clearance Saturation on Propylene Glycol Exposure in Adults and Term Neonates Using Physiologically Based Pharmacokinetic ModelingOlusola Olafuyi, Robin Michelet, Michael Garle, et al.
Pharmaceutics|September 23, 2022
The Impact of Low Cardiac Output on Propofol Pharmacokinetics across Age Groups-An Investigation Using Physiologically Based Pharmacokinetic ModellingKarel Allegaert, Mohammad Yaseen Abbasi, Robin Michelet, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 10, 2018
The use of PBPK modeling across the pediatric age range using propofol as a caseRobin Michelet, Jan Van Bocxlaer, Karel Allegaert, et al.
Drug Metabolism Reviews|June 20, 2019
Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolismJosefine Schulz, Franziska Kluwe, Gerd Mikus, et al.
Pharmaceutical Research|September 28, 2022
Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxideJosefine Schulz, Robin Michelet, Markus Zeitlinger, et al.
Pharmaceutical Research|October 22, 2022
Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in HumansJosefine Schulz, Robin Michelet, Markus Zeitlinger, et al.
Archives of Toxicology|May 24, 2021
CYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxicationsAnna Mueller-Schoell, Robin Michelet, Ferdinand Weinelt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 31, 2025
Breaking barriers: The novel in vitro microdialysis system enables reproducing in vivo extraction efficiencies of linezolidFelix Leon Müller, Davide Bindellini, Gerd Mikus, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|May 17, 2021
Quantification of persister formation of Escherichia coli leveraging electronic cell counting and semi-mechanistic pharmacokinetic/pharmacodynamic modellingJohanna Seeger, Robin Michelet, Charlotte Kloft
Current Pharmaceutical Design|October 10, 2017
PBPK in Preterm and Term Neonates: A ReviewRobin Michelet, Jan Van Bocxlaer, An Vermeulen
Journal of Clinical Pharmacology|October 15, 2024
Exploring the Impact of Developmental Clearance Saturation on Propylene Glycol Exposure in Adults and Term Neonates Using Physiologically Based Pharmacokinetic ModelingOlusola Olafuyi, Robin Michelet, Michael Garle, et al.
Pharmaceutics|September 23, 2022
The Impact of Low Cardiac Output on Propofol Pharmacokinetics across Age Groups-An Investigation Using Physiologically Based Pharmacokinetic ModellingKarel Allegaert, Mohammad Yaseen Abbasi, Robin Michelet, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 10, 2018
The use of PBPK modeling across the pediatric age range using propofol as a caseRobin Michelet, Jan Van Bocxlaer, Karel Allegaert, et al.
Drug Metabolism Reviews|June 20, 2019
Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolismJosefine Schulz, Franziska Kluwe, Gerd Mikus, et al.
Pharmaceutical Research|September 28, 2022
Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxideJosefine Schulz, Robin Michelet, Markus Zeitlinger, et al.
Pharmaceutical Research|October 22, 2022
Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in HumansJosefine Schulz, Robin Michelet, Markus Zeitlinger, et al.
Archives of Toxicology|May 24, 2021
CYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxicationsAnna Mueller-Schoell, Robin Michelet, Ferdinand Weinelt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 31, 2025
Breaking barriers: The novel in vitro microdialysis system enables reproducing in vivo extraction efficiencies of linezolidFelix Leon Müller, Davide Bindellini, Gerd Mikus, et al.
Pageof 8